Okay, let's tackle this question about the marker for menopause transition. First, I need to recall what the menopause transition involves. The menopause transition, also known as perimenopause, is the period during which a woman's reproductive system begins to wind down, leading to menopause. Hormonal changes are key here, especially in estrogen and follicle-stimulating hormone (FSH) levels.

The question is asking for a specific marker. Common markers I remember are related to hormone levels. For example, FSH levels tend to rise as ovarian function declines. But wait, there's also anti-Müllerian hormone (AMH), which is produced by the ovarian follicles. AMH levels decrease as the ovarian reserve diminishes. So, low AMH might indicate the menopause transition.

Another possibility is inhibin B, which is produced by the granulosa cells of the follicles. Its levels drop as ovarian reserve decreases. Then there's estradiol, which might fluctuate during this period. But I think the primary marker is AMH because it's more specific to the ovarian reserve.

Looking at the options (even though they aren't listed here), the correct answer is likely AMH. Let me verify: during the menopause transition, the ovarian follicle count decreases, leading to lower AMH. FSH might be elevated, but that's more of a result of the feedback loop due to lower estrogen. So AMH is a direct marker of ovarian reserve, making it the best choice. The other options like inhibin B or estradiol might be part of the picture but not the primary marker. Clinical pearl: AMH levels are used in assessing ovarian reserve and predicting menopause timing.

**Core Concept**
The menopause transition involves hormonal changes reflecting declining ovarian reserve. **Anti-Müllerian hormone (AMH)** is a key marker of ovarian follicle quantity and function, produced by granulosa cells in preantral and antral follicles.

**Why the Correct Answer is Right**
AMH levels directly correlate with the number of primordial follicles. During menopause transition, AMH declines as follicular depletion occurs, making it a specific and sensitive biomarker. Unlike FSH, which can fluctuate due to feedback mechanisms, AMH provides a stable assessment of ovarian reserve.

**Why Each Wrong Option is Incorrect**
**Option A:** *Inhibin B* decreases in perimenopause but is less specific for tracking the menopause transition.
**Option B:** *Estradiol* levels become irregular during perimenopause but do not reliably indicate follicular depletion.
**Option C:** *FSH* rises later in menopause due to reduced negative feedback from estrogen, but it is not the earliest or most specific marker.

**Clinical Pearl**
AMH testing is superior to FSH for predicting menopause onset. Remember: low AMH (<1.1 ng/mL) correlates with diminished ovarian reserve and impending menopause. **Correct Answer: C. Anti-Müllerian hormone (AMH)**

✓ Correct Answer: A. Menstrual irregularity